A relook at gastroenteropancreatic neuroendocrine tumours as per 2019 WHO classification—A tertiary centre experience-Reference-Cited by-同舟云学术

A relook at gastroenteropancreatic neuroendocrine tumours as per 2019 WHO classification—A tertiary centre experience

Published:2022-11-21 Issue: Volume: Page:
ISSN:0021-1265
Container-title:Irish Journal of Medical Science (1971 -)
language:en
Short-container-title:Ir J Med Sci

Author:

Ail Divya Achutha^ORCID,Paulose Roopa Rachel^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11845-022-03217-1.pdf

Reference23 articles.

1. Kim JY, Hong SM (2016) Recent updates on neuroendocrine tumors from the gastrointestinal and pancreatobiliary tracts. Arch Pathol Lab Med 140:437–448. https://doi.org/10.5858/arpa.2015-0314-RA

2. Lokuhetty D, White V, Watanabe R, Cree I (2018) WHO classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer

3. Basturk O, Yang Z, Tang LH et al (2015) The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms. Am J Surg Pathol 39:683–690. https://doi.org/10.1097/pas.0000000000000408

4. Tang LH, Basturk O, Sue JJ, Klimstra DS (2016) A practical approach to the classification of WHO grade 3 (G3) well differentiated neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of the pancreas. Am J Surg Pathol 40:1192. https://doi.org/10.1097/pas.0000000000000662

5. Park JK, Paik WH, Lee K et al (2017) DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors. Oncotarget 8:49796. https://doi.org/10.18632/oncotarget.17964

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis;Journal of Cancer Research and Therapeutics;2024-04